United States Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

United States Pharmaceuticals and Healthcare Report Q3 2013 Jun 19th 2013, 00:00 BMI View: The necessity of reducing healthcare spending by both the public and private sectors in the US is having a direct downward effect on prescription drug expenditure. The government, employers and families can readily identify with medicine cost containment, but have difficulty lowering spending on more nebulous areas such as healthcare administration, technology and intermediaries in the supply chain. There is also the inherent difficulty of reducing the wages of medical personnel, which account for a sizeable proportion of total healthcare spending. Downwards pressure on revenue generated by prescription drug firms will become increasingly common, as early efforts to … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=103233. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/united-states-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions